• <kbd id="hmaqz"></kbd>
  • <blockquote id="hmaqz"><del id="hmaqz"><legend id="hmaqz"></legend></del></blockquote>
    The Current Position:Home > News Center
    News Center
    Innovative Antitumor Drug ACC006 Received CFDA Approval for Clinical Trials
    2016-11-03 Source:江蘇艾迪藥業有限公司
             Clinical trial of ACC006, an innovative antitumor drug has been officially approved by China Food and Drug Administration (CFDA) on October 20th , 2016. ACC006 is the first innovative drug in Aidea’s pipeline with intellectual property rights. This IND approval marks an important milestone in history of Aidea’s research and development for innovative drugs..

    Jiangsu Aidea Pharmaceutical Co., Ltd
    Address:No.2 Liuzhuang Road, Hanjiang District, Yangzhou
    版權歸 ? "Jiangsu Aidea Pharmaceutical Co., Ltd所有 蘇ICP備14046468號 Powered by vancheer